Comparative Study on Grouping Rules in Centralized Volume-based Procurement of Chinese Patent Medicine

Corresponding author: CHEN Yong-fa, cyf990@163.com

DOI: 10.12201/bmr.202312.00008

•  

  Abstract: Objective: Comprehensively review national and provincial policies related to centralized procurement of Chinese patent medicines (CPM) and to compare the grouping rules and methods of centralized procurement in different regions, with the goal of providing guidance for enhancing the grouping rules for CPM. Methods: Through literature analysis and comparative analysis, the 22 policies included in the study were analyzed in depth, and the progress of centralized procurement of CPM in national and inter-provincial alliances was compared and summarized. Results: National and inter-provincial alliances’ centralized volume-based procurement of CPM divides procurement groups according to functional indications, route of administration, and market conditions. The grouping rules are not closely related to drug dosage forms and quality. Dividing bidding groups based on the market competition pattern ignores the innovative value of some CPM , and does not take into account the unique brand value of the company and its drugs. The completeness of the grouping rules needs to be improved. Conclusions: There are many dosage forms of CPM and complex quality control indicators. The existing grouping rules follow the idea of grouping chemical drugs and lack a top-level design oriented to the value of CPM. It is recommended to adopt a diversified grouping method and advance the technical evaluation link in the existing shortlisting rules. This means that factors such as drug dosage form, quality, innovation value, and improvement of cultural soft power should be considered when formulating grouping rules. At the same time, it is necessary to improve and refine the current grouping rules.

  Key words: Chinese patent medicines; centralized volume-based procurement; grouping rules.

  Submit time: 4 December 2023

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• LIU MINGZHU, LU YUN. Research on the Implementation Effect of Expiration of National Pharmaceutical Centralized Volume-based Procurement Based on Intermittent Time Series: A Case Study of Hebei Province. 2023. doi: 10.12201/bmr.202306.00007

  Sun Yan, Zhu Zheng, Yang Li. Influencing factors analysis on price reduction in national volume-based drug procurement.. 2022. doi: 10.12201/bmr.202203.00008

  WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. A study of price reduction sustainability in national volume-based drug procurement. 2023. doi: 10.12201/bmr.202305.00008

  ZENGXUHENG, ZHENGJI, LVJUN, NINGYULING, LIXIAOHONG. SWOT analysis on volume-based procurement of high-value medical consumables: A case of Shanghai. 2020. doi: 10.12201/bmr.202010.00841

  songjia, fanchengxin, wangwanchen, aixufeng, liuxinlu, licuiyu, zhangyujie, liqiusha, wanganqi, fengzhiqiang, yinwenqiang, madongping. Study on Chinas centralized quantity purchasing policy for drugs from the perspective of stakeholders - a textual analysis based on policy tools. 2022. doi: 10.12201/bmr.202203.00006

  WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. Research on the price difference and regional distribution of selected drugs in Chinas centralized procurement. 2023. doi: 10.12201/bmr.202306.00008

  Tang Yuqing, Li Yinming, Chen Xizhuo, Xue Tianqin, Chen Hao. Analysis of the Execution of Centralized Drug Procurement Policy Based on Policy Implementation System Model. 2023. doi: 10.12201/bmr.202310.00002

  LI Zhao, Zhao Ke, Zhou Lulin, Chen Sheng. Research on the Comparison and Development Countermeasures of Pharmaceutical Group Purchasing Modes from the Perspective of the Normalization of National Centralized Procurement. 2021. doi: 10.12201/bmr.202109.00037

  SUN Wenjun, ZHAO Ziyin, CHENG Zheyu, LI Huining, ZHU He. Impact of the national centralized drug procurement policy on drug prices and utilization: a systematic review. 2023. doi: 10.12201/bmr.202303.00033

  LiYu, Yang Tao, Hu Kongfa. Research on Medication Rules of Famous TCM Physicians in Treating Lung Cancer Based on Hierarchical Community Partition Algorithm. 2021. doi: 10.12201/bmr.202110.00020

• ID	Submit time	Number	Download
  1	2023-06-16	bmr.202312.00008V1	Download

• Public  Anonymous  To author only Submit Comments